CAB, R., PD, M., RRM, M., ITS, G., VLS, R., & O, M. (2023). Antibacterial polypeptide-bioparticle for oral administration: Powder formulation, palatability and in vivo toxicity approach. Biomaterials advances, 153, 213525. https://doi.org/10.1016/j.bioadv.2023.213525
Chicago Style (17th ed.) CitationCAB, Ramirez, Mathews PD, Madrid RRM, Garcia ITS, Rigoni VLS, and Mertins O. "Antibacterial Polypeptide-bioparticle for Oral Administration: Powder Formulation, Palatability and in Vivo Toxicity Approach." Biomaterials Advances 153 (2023): 213525. https://doi.org/10.1016/j.bioadv.2023.213525.
MLA (9th ed.) CitationCAB, Ramirez, et al. "Antibacterial Polypeptide-bioparticle for Oral Administration: Powder Formulation, Palatability and in Vivo Toxicity Approach." Biomaterials Advances, vol. 153, 2023, p. 213525, https://doi.org/10.1016/j.bioadv.2023.213525.